Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice

Last updated: June 24, 2024
Sponsor: Seung-Jung Park
Overall Status: Active - Recruiting

Phase

N/A

Condition

Heart Disease

Vascular Diseases

Chest Pain

Treatment

XIENCE Skypoint™ stent

Clinical Study ID

NCT05981911
AMCCV2023-04
  • Ages > 19
  • All Genders

Study Summary

The objective of this study is to evaluate the effectiveness and safety of XIENCE Skypoint stents in comparison to other drug-eluting stents (DES) in real-world practice.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Patients ≥ 19 years old

  2. Patients receiving Xience-Skypoint™ stents.

  3. The patient or guardian agrees to the study protocol and the schedule of clinicalfollow-up, and provides informed, written consent, as approved by the appropriateInstitutional Review Board/Ethics Committee of the respective clinical site.

Exclusion

Exclusion Criteria:

  1. Patients with a mixture of other DESs

  2. Terminal illness with life expectancy <1 year

  3. Patients with cardiogenic shock

Study Design

Total Participants: 2000
Treatment Group(s): 1
Primary Treatment: XIENCE Skypoint™ stent
Phase:
Study Start date:
December 14, 2023
Estimated Completion Date:
February 28, 2026

Connect with a study center

  • Asan Medical Hospital

    Seoul,
    Korea, Republic of

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.